Trials / Recruiting
RecruitingNCT06604260
FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Dalia Lartey · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Our main objective is to evaluate the feasibility of 68Ga-FAPi PET/CT in detecting intestinal fibrosis in patients with IBD. To this end, we will determine 68Ga-FAPi uptake in IBD in relation to cellular FAP expression in intestinal biopsies and resection specimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 68Ga-FAPi-46 | 68Ga FAPi PET-CT scan |
Timeline
- Start date
- 2023-08-31
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2024-09-19
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT06604260. Inclusion in this directory is not an endorsement.